{"symbol": "BIOC", "companyName": "Biocept Inc.", "exchange": "NASDAQ Capital Market", "industry": "Medical Diagnostics & Research", "website": "http://www.biocept.com", "description": "Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample.", "CEO": "Michael W. Nall", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Diagnostics & Research", "Medical Diagnostics & Research"]}